| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |